Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging therapeutic targets for neuroblastoma. | Expert Opin Ther Targets | 2020 | 33021426 | PubTator, text mining | PubMed |
| Establishment and Investigation of a Multiple Gene Expression Signature to Predict Long-Term Survival in Pancreatic Cancer. | Biomed Res Int | 2020 | 33015155 | PubTator, text mining | PubMed |
| Frequency and Prognostic Value of IDH Mutations in Korean Patients With Cholangiocarcinoma. | Front Oncol | 2020 | 33014795 | PubTator, text mining | PubMed |
| Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review). | Int J Mol Med | 2020 | 33000182 | PubTator, text mining | PubMed |
| Three Novel EGFR Mutations (750_758del, I759S, T751_I759delinsS) in One Patient with Metastatic Non-Small Cell Lung Cancer Responding to Osimertinib: A Case Report. | Onco Targets Ther | 2020 | 32982275 | PubTator, text mining | PubMed |
| Using next-generation sequencing of microRNAs to identify host and/or pathogen nucleic acid signatures in samples from children with biliary atresia - a pilot study. | Access Microbiol | 2020 | 32974591 | PubTator, text mining | PubMed |
| Small nucleolar RNA host gene 22 (SNHG22) promotes the progression of esophageal squamous cell carcinoma by miR-429/SESN3 axis. | Ann Transl Med | 2020 | 32953807 | PubTator, text mining | PubMed |
| LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1. | Transl Lung Cancer Res | 2020 | 32953492 | PubTator, text mining | PubMed |
| Integrated Bioinformatics analysis and clinical validation reveals that high expression of mucin 1 in intrahepatic cholangiocarcinoma predicts recurrence after curative resection. | Exp Ther Med | 2020 | 32952640 | PubTator, text mining | PubMed |
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the KRAS (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature. | J Pers Med | 2020 | 32947833 | PubTator, text mining | PubMed |
| A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. | Theranostics | 2020 | 32929338 | PubTator, text mining | PubMed |
| Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma. | Technol Cancer Res Treat | 2020 | 32924793 | PubTator, text mining | PubMed |
| Analysis of Differentially Expressed Long Non-coding RNAs and the Associated TF-mRNA Network in Tongue Squamous Cell Carcinoma. | Front Oncol | 2020 | 32923393 | PubTator, text mining | PubMed |
| Differentially expressed full-length, fusion and novel isoforms transcripts-based signature of well-differentiated keratinized oral squamous cell carcinoma. | Oncotarget | 2020 | 32922662 | PubTator, text mining | PubMed |
| Multiple neuroprotective features of Scutellaria pinnatifida-derived small molecule. | Heliyon | 2020 | 32913905 | PubTator, text mining | PubMed |
| IgE Autoreactivity in Atopic Dermatitis: Paving the Road for Autoimmune Diseases? | Antibodies (Basel) | 2020 | 32911788 | PubTator, text mining | PubMed |
| LAMB3 Missense Variant in Australian Shepherd Dogs with Junctional Epidermolysis Bullosa. | Genes (Basel) | 2020 | 32906717 | PubTator, text mining | PubMed |
| Transcriptome sequencing identifies genes associated with invasion of ovarian cancer. | J Int Med Res | 2020 | 32878513 | PubTator, text mining | PubMed |
| Expression Profiling of Extracellular Matrix Genes Reveals Global and Entity-Specific Characteristics in Adenoid Cystic, Mucoepidermoid and Salivary Duct Carcinomas. | Cancers (Basel) | 2020 | 32878206 | PubTator, text mining | PubMed |
| Composition of hemidesmosomes in basal keratinocytes of normal buccal mucosa and oral lichen planus. | Eur J Oral Sci | 2020 | 32870574 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=50